| 5.39 -0.11 (-2%) | 10-02 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |   |
|||
| Targets | 6-month : | 7.39 | 1-year : | 8.63 |
| Resists | First : | 6.32 | Second : | 7.39 |
| Pivot price | 1.94 |
|||
| Supports | First : | 2.76 | Second : | 0.56 |
| MAs | MA(5) : | 4.5 |
MA(20) : | 1.62 |
| MA(100) : | 0.87 |
MA(250) : | 1.1 |
|
| MACD | MACD : | 1 |
Signal : | 0.4 |
| %K %D | K(14,3) : | 86.5 |
D(3) : | 78.3 |
| RSI | RSI(14): 89 |
|||
| 52-week | High : | 6.32 | Low : | 0.49 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ ONMD ] has closed below upper band by 9.5%. Bollinger Bands are 1581.1% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 3 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 5.64 - 5.68 | 5.68 - 5.71 |
| Low: | 5.28 - 5.32 | 5.32 - 5.35 |
| Close: | 5.34 - 5.4 | 5.4 - 5.44 |
OneMedNet Corporation offers advanced solutions for clinical imaging. Their core product, iRWD, is an artificial intelligence-driven platform that securely anonymizes, searches for, and organizes imaging data. This system is utilized by their extensive network of medical and academic research institutions, with the goal of fostering significant progress in medical research, new discoveries, and diagnostic techniques across the broader field of life sciences. The company's operations are based out of Eden Prairie, Minnesota.
Thu, 01 Oct 2026
Insiders' US$3.22m Investments In Red Following OneMedNet's US$7.5m Dip In Market Value - Simply Wall Street
Wed, 30 Sep 2026
Onemednet Signs Seven Figure Multiyear Agreement to Power A Partner Sold Derivative Data Solution - marketscreener.com
Wed, 30 Sep 2026
OneMedNet secures seven-figure AI data licensing deal - Investing.com
Wed, 30 Sep 2026
OneMedNet Signs Seven Figure Multiyear Agreement to Power a Partner Sold Derivative Data Solution - Yahoo Finance
Wed, 30 Sep 2026
A health AI company plans to sell a medical dataset. OneMedNet earns each time buyers license it. - Stock Titan
Fri, 25 Sep 2026
Ten OneMedNet shares will become one; ownership stakes stay the same, except for fractional shares. - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 59 (M) |
| Shares Float | 19 (M) |
| Held by Insiders | 69.7 (%) |
| Held by Institutions | 30.3 (%) |
| Shares Short | 722 (K) |
| Shares Short P.Month | 346 (K) |
| EPS | -0.18 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -0.06 |
| Profit Margin | 0 % |
| Operating Margin | -774.4 % |
| Return on Assets (ttm) | -342.2 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 88.4 % |
| Gross Profit (p.s.) | -0.03 |
| Sales Per Share | 0.02 |
| EBITDA (p.s.) | -0.18 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -7 (M) |
| Levered Free Cash Flow | -4 (M) |
| PE Ratio | -31.71 |
| PEG Ratio | 0 |
| Price to Book value | -89.84 |
| Price to Sales | 218.88 |
| Price to Cash Flow | -46.45 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|